Our Science

SPM™ is a bio-composition where cell activating ingredients are effectively compounded

Our Pipeline

HOME > Our Science > Our Pipeline

Pharmaceuticals

BIOCOZ GLOBAL is studying a number of new drug candidate substances utilizing the cell regeneration efficacy of SPM™ and its synergistic properties .
We are also conducting preliminary research, in-vitro studies, and animal studies on some new drug candidates. We plan to complete drug development sequentially through clinical procedures starting from the year 2020.

Indications 2019 2020 2021-24 2025
[BG_12_1001]
In-vitro/Animal Pre-Clinical
Clinical
Sales
[BG_12_1002]
In-vitro/Animal study
Pre-Clinical Clinical Sales
[BG_12_1003]
In-vitro/Animal study
Pre-Clinical Clinical Sales
[BG_12_2001]
Preliminary Study
In-vitro/Animal study Pre-Clinical Clinical
[BG_12_2002]
Preliminary Study In-vitro/Animal study Pre-Clinical Clinical
[BG_12_2003]
Preliminary Study In-vitro/Animal study
Pre-Clinical Clinical
Indications 2019 2020 2021-2024 2025
[BG_12_1001]
V/A PC
CL
SA
[BG_12_1002]
V/A
PC CL SA
[BG_12_1003]
V/A
PC CL SA
[BG_12_2001]
PS
V/A PC CL
[BG_12_2002]
PS V/A PC CL
[BG_12_2003]
PS V/A
PC CL
  • Preliminary
  • In-vitro / Animal
  • Pre-Clinicall
  • Clinical
  • Sales

Medical Devices

Considering that pharmaceuticals take a relatively long time to commercialize, we are pursuing a strategy to expedite the market access by simultaneously developing medical devices. Medical device licensing procedures will be extended from the US FDA to other countries. After launching general-purpose wound management products, we plan to launch products that differentiating symptoms and application methods.
Currently, we are preparing US FDA procedures to launch three types of medical devices to be registered in 2019.

Products 2019 2020 2021 2022 2023 2024
Wound Dressing (Prototypical) Class I
Product Preparation Sales
Classified [B]Class II
Product Development FDA Review Sales
Diabetic Foot CareClass II
Product Development FDA Review Sales
Eye Drop Class II
Product Development FDA Review Sales
Classified [P]Class II
Product Development FDA Review Sales
Atopic Dermatitis CareClass II
Product Development FDA Review Sales
Eczema Dermatitis CareClass II
Product Development FDA Review Sales
Classified [D]Class III
Product Development Clinical FDA Review Sales
Products 2019 2020 2021 2022 2023 2024
Wound Dressing (Prototypical)Class I
PP SA
Classified [B]Class II
PD FDA SA
Diabetic Foot CareClass II
PD FDA SA
Eye Drop Class II
PD FDA SA
Classified [P]Class II
PD FDA SA
Atopic Dermatitis CareClass II
PD FDA SA
Eczema Dermatitis CareClass II
PD FDA SA
Classified [D]Class III
PD CL FDA SA
  • Prod. Preparation
  • Prod. Development
  • FDA Review
  • Clinical
  • Sales